Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights

Patients with asthma are somewhat protected from COVID-19 complications compared to COPD. This may be due to variability in viral attachment protein, ICS use, smoking/vaping status, a skewed inflammatory pattern, and dysregulated endocytic machinery. https://bit.ly/3qOcyNb

Detalles Bibliográficos
Autores principales: Wark, Peter A.B., Pathinayake, Prabuddha S., Eapen, Mathew Suji, Sohal, Sukhwinder Singh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287734/
https://www.ncbi.nlm.nih.gov/pubmed/34244320
http://dx.doi.org/10.1183/13993003.00920-2021
Descripción
Sumario:Patients with asthma are somewhat protected from COVID-19 complications compared to COPD. This may be due to variability in viral attachment protein, ICS use, smoking/vaping status, a skewed inflammatory pattern, and dysregulated endocytic machinery. https://bit.ly/3qOcyNb

Ejemplares similares